CLR Roasters Expands Supply Base and Manufacturing Capacity to Support Growth
Company Receives New Contract Agreements in the Hospitality, Private label, and Retail Sectors
SAN DIEGO–(BUSINESS WIRE)–CLR Roasters, LLC, a wholly owned subsidiary of AL International, Inc. (PINKSHEETS: JCOF), announces it has expanded its green coffee supply base with the addition of three new green coffee growers. Initial supply contracts for over 1.4 million pounds of green coffee have been executed to support new contracts and contract extensions from Signature Wellness Centers, Cruise Lines, and the Private Label Sector clients. These contracts represent over $4 million in business.
Dave Briskie, CFO and President of Commercial Development, stated, “We are experiencing robust growth in a number of business sectors. We have recently been awarded expanded contracts in our Hospitality Sector, including new contracts in the Cruise Line business. We have also extended our contract with Signature Wellness Centers through August 2013, and we have received a six-month contract extension from our largest client in the Private Label Retail sector. CLR Roasters has experienced 70 percent growth year-to-date and we anticipate its output will accelerate through the balance of 2012.”
The company also announced that CLR Roasters Company-owned Josie’s Java House Brand, which recently has become a fully registered trademark of the company, has been added to Walmart’s product assortment for distribution beginning this fall. Additionally, the company-owned Café La Rica brand has been added to Sam’s Club’s fall assortment, and the brand has been approved for distribution in Publix supermarkets.
To support this growth, the previously announced purchase of two new packaging machines and a new high-output commercial grinder have been brought on line and became operational early this month.
Steve Wallach, CEO of AL International (JCOF), said, “We are quite pleased with the growth we are experiencing through all divisions of the company and we are especially pleased with the recent contracts and contract extensions earned by CLR Roasters, which will positively impact the second half of this year. Obviously, this news, our continued organic growth in our direct selling division and with our Audit, Q1 Review and Form 10 nearly complete, there is a lot to look forward to in the second half of 2012.”
About Youngevity® Essential Life Sciences
Youngevity Essential Life Sciences (www.Youngevity.com), headquartered in San Diego, CA, is a nutrition and lifestyle-related services company dedicated to promoting vibrant health and flourishing economics. Founded in 1997 by Drs. Joel Wallach, DVM, ND, and Ma Lan, MD, as AL Global, Inc., the company adopted the name Youngevity in 2006. Youngevity is the only network marketing company to have a qualified FDA Health Claim. Dr. Wallach’s work has been published in more than 70 peer-reviewed and referenced scientific journals and books.
About AL International
AL International, Inc. (PINKSHEETS: JCOF) (www.alintjcof.com) is a fast-growing, innovative, multi-dimensional company that offers a wide range of consumer products and services, primarily through person-to-person selling relationships that comprise a “network of networks.” The company also is a vertically integrated producer of the finest coffees for the commercial, retail and direct sales channels. AL International was formed after the merger of Youngevity Essential Life Sciences (www.Youngevity.com) and Javalution Coffee Company in the summer of 2011.
CLR Roasters, LLC
CLR Roasters (www.cafelarica.com) was established in 2001 and is a wholly owned subsidiary of AL International, Inc. CLR Roasters produces coffees under its own Café La Rica brand, as well as under a variety of private labels through major national sales outlets and to major customers. It also produces a unique line of coffees with health benefits under the JavaFit® brand.
Safe Harbor Statement
This release includes forward-looking statements on our current expectations and projections about future events. In some cases forward-looking statements can be identified by terminology such as “may,” “should,” “potential,” “continue,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” and similar expressions. These statements are based upon current beliefs, expectations and assumptions and are subject to a number of risks and uncertainties, many of which are difficult to predict and include statements relating to our business plan and growth strategy through acquisition. The forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from those reflected in our forward-looking statements include, among others, the ability to implement our business plan and growth strategy through acquisition and the continued growth of our distributor base. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release based on new information, future events, or otherwise, except as required by law.
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.